SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Remington L. Nevin, Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine, International Journal for Parasitology: Drugs and Drug Resistance, 2014, 4, 2, 118

    CrossRef

  2. 2
    Jinyue Ding, Dennis G. Hall, Concise Synthesis and Antimalarial Activity of All Four Mefloquine Stereoisomers Using a Highly Enantioselective Catalytic Borylative Alkene Isomerization, Angewandte Chemie International Edition, 2013, 52, 31
  3. 3
    Jinyue Ding, Dennis G. Hall, Concise Synthesis and Antimalarial Activity of All Four Mefloquine Stereoisomers Using a Highly Enantioselective Catalytic Borylative Alkene Isomerization, Angewandte Chemie, 2013, 125, 31
  4. 4
    Arzneimittel in Schwangerschaft und Stillzeit, 2012,

    CrossRef

  5. 5
    Goran Gajski, Domagoj Dinter, Vera Garaj-Vrhovac, In vitro effect of the antimalarial drug proguanil hydrochloride on viability and DNA damage in human peripheral blood lymphocytes, Environmental Toxicology and Pharmacology, 2010, 30, 3, 257

    CrossRef

  6. 6
    Roberto Romi, Daniela Boccolini, Stefania D'Amato, Corrado Cenci, Mario Peragallo, Fortunato D'Ancona, Maria Grazia Pompa, Giancarlo Majori, Incidence of malaria and risk factors in Italian travelers to malaria endemic countries, Travel Medicine and Infectious Disease, 2010, 8, 3, 144

    CrossRef

  7. 7
    THOMAS A. MOORE, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  8. 8
    Patricia Schlagenhauf, Richard Johnson, Eli Schwartz, Hans D. Nothdurft, Robert Steffen, Evaluation of Mood Profiles During Malaria Chemoprophylaxis: A Randomized, Double-Blind, Four-Arm Study, Journal of Travel Medicine, 2009, 16, 1
  9. 9
    Raewadee Wisedpanichkij, Wanna Chaijaroenkul, Piyanan Sangsuwan, Jintana Tantisawat, Kanyarat Boonprasert, Kesara Na-Bangchang, In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors, Acta Tropica, 2009, 112, 1, 12

    CrossRef

  10. 10
    Thierry Pistone, Michaël Schwarzinger, Pierre Chauvin, Khaled Ezzedine, Marie-Catherine Receveur, Félix Djossou, Mahinda Siriwardana, Bernard Larouzé, Denis Malvy, Reimbursement of malaria chemoprophylaxis for travellers from Europe to Sub-Saharan Africa: Cost-effectiveness analysis from the perspective of the French national health insurance system, Health Policy, 2008, 88, 2-3, 186

    CrossRef

  11. 11
    Andrew Vallely, James McCarthy, John Changalucha, Lisa Vallely, Daniel Chandramohan, Treating malaria in pregnancy in developing countries: priorities in clinical research and drug development, Expert Review of Clinical Pharmacology, 2008, 1, 1, 61

    CrossRef

  12. 12
    Hussien O. AlKadi, Antimalarial Drug Toxicity: A Review, Chemotherapy, 2007, 53, 6, 385

    CrossRef

  13. 13
    Rana Chattopadhyay, Babita Mahajan, Sanjai Kumar, Assessment of safety of the major antimalarial drugs, Expert Opinion on Drug Safety, 2007, 6, 5, 505

    CrossRef

  14. 14
    Hanneke Garbis, Margreet Rost van Tonning, Minke Reuvers, Drugs During Pregnancy and Lactation, 2007,

    CrossRef

  15. 15
    Hanneke Garbis, Margreet Rost van Tonningen, Minke Reuvers, Drugs During Pregnancy and Lactation, 2007,

    CrossRef

  16. 16
    Charles D. Ericsson, Wilderness Medicine, 2007,

    CrossRef

  17. 17
    C. F. R. Hatz, H. D. Nothdurft, Aktueller Malariaschutz bei Kurzzeitaufenthalt, Der Internist, 2006, 47, 8, 810

    CrossRef

  18. 18
    Huck Chin Chew, R. Ponampalam, An unusual cutaneous manifestation with mefloquine, The American Journal of Emergency Medicine, 2006, 24, 5, 634

    CrossRef

  19. 19
    Fredricka C. Martin, Adrian Handforth, Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor, Movement Disorders, 2006, 21, 10
  20. 20
    Elizabeth Ashley, Rose McGready, Stephane Proux, François Nosten, Malaria, Travel Medicine and Infectious Disease, 2006, 4, 3-4, 159

    CrossRef

  21. 21
    Carlos Franco-Paredes, José Ignacio Santos-Preciado, Problem pathogens: prevention of malaria in travellers, The Lancet Infectious Diseases, 2006, 6, 3, 139

    CrossRef

  22. 22
    Nathalie Jousset, Michel Guilleux, Ludovic de Gentile, Anne Le Bouil, Alain Turcant, Clotilde Rougé-Maillart, Suicide spectaculaire lié à une prise de méfloquine, La Presse Médicale, 2006, 35, 5, 789

    CrossRef

  23. 23
    D. R. Hill, C. D. Ericsson, R. D. Pearson, J. S. Keystone, D. O. Freedman, P. E. Kozarsky, H. L. DuPont, F. J. Bia, P. R. Fischer, E. T. Ryan, The Practice of Travel Medicine: Guidelines by the Infectious Diseases Society of America, Clinical Infectious Diseases, 2006, 43, 12, 1499

    CrossRef

  24. 24
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  25. 25
    Geoffrey S. Dow, Diana Caridha, Michelle Goldberg, Lesley Wolf, Michael L. Koenig, Debra L. Yourick, Zhining Wang, Transcriptional profiling of mefloquine-induced disruption of calcium homeostasis in neurons in vitro, Genomics, 2005, 86, 5, 539

    CrossRef

  26. 26
    Jane Wilson-Howarth, Travel in pregnancy, Women's Health Medicine, 2005, 2, 2, 6

    CrossRef

  27. 27
    Jürgen Knobloch, Long-Term Malaria Prophylaxis for Travelers, Journal of Travel Medicine, 2004, 11, 6
  28. 28
    Alan M Spira, Preparing the traveller, The Lancet, 2003, 361, 9366, 1368

    CrossRef

  29. 29
    Rogelio López-Vélez, Prevención de la malaria en los viajes internacionales, Enfermedades Infecciosas y Microbiología Clínica, 2003, 21, 5, 248

    CrossRef

  30. 30
    O. Wichmann, B. Betschart, T. Löscher, H.D. Nothdurft, F.V. Sonnenburg, Tomas Jelinek, Prophylaxis failure due to probable mefloquine resistant P. falciparum from Tanzania, Acta Tropica, 2003, 86, 1, 63

    CrossRef

  31. 31
    Charlotte EC Kingman, Demetrios L Economides, Air travel in pregnancy, The Obstetrician & Gynaecologist, 2002, 4, 4
    Direct Link:
  32. 32
    Israel Potasman, Yoav Juven, Boaz Weller, Eli Schwartz, Does mefloquine prophylaxis affect electroencephalographic patterns?, The American Journal of Medicine, 2002, 112, 2, 147

    CrossRef

  33. 33
    P. R. Fischer, R. Bialek, Prevention of Malaria in Children, Clinical Infectious Diseases, 2002, 34, 4, 493

    CrossRef

  34. 34
    Alan J. Magill, The prevention of malaria, Primary Care: Clinics in Office Practice, 2002, 29, 4, 815

    CrossRef

  35. 35
    Pamela Rendi-Wagner, Harald Noedl, Walther H. Wernsdorfer, Gerhard Wiedermann, Andrea Mikolasek, Herwig Kollaritsch, Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults, Acta Tropica, 2002, 81, 2, 167

    CrossRef

  36. 36
    Oliver Kayser, Albrecht F. Kiderlen, Simon L. Croft, Bioactive Natural Products, 2002,

    CrossRef

  37. 37
    Michael H. Kramer, Hans O. Lobel, Antimalarial Chemoprophylaxis in Infants and Children, Paediatric Drugs, 2001, 3, 2, 113

    CrossRef

  38. 38
    Elaine C. Jong, Hans D. Nothdurft, Current Drugs for Antimalarial Chemoprophylaxis: A Review of Efficacy and Safety, Journal of Travel Medicine, 2001, 8,
  39. 39
    Bradley A. Connor, Expert Recommendations for Antimalarial Prophylaxis, Journal of Travel Medicine, 2001, 8,
  40. 40
    Stephen Watt-Smith, Kuljeet Mehta, Crispian Scully, Mefloquine-induced trigeminal sensory neuropathy, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2001, 92, 2, 163

    CrossRef

  41. 41
    François-Xavier Borruat, Bernard Nater, Luc Robyn, Blaise Genton, Prolonged Visual Illusions Induced by Mefloquine (Lariam®): A Case Report, Journal of Travel Medicine, 2001, 8, 3
  42. 42
    Timothy J Egan, Quinoline antimalarials, Expert Opinion on Therapeutic Patents, 2001, 11, 2, 185

    CrossRef

  43. 43
    Annie-Claude Labbé, Mona R. Loutfy, Kevin C. Kain, Recent advances in the prophylaxis and treatment of malaria, Current Infectious Disease Reports, 2001, 3, 1, 68

    CrossRef

  44. 44
    Christopher J.M. Whitty, Sanjeev Krishna, 2001,

    CrossRef

  45. 45
    David R. Hill, Health Problems in a Large Cohort of Americans Traveling to Developing Countries, Journal of Travel Medicine, 2000, 7, 5
  46. 46
    Patricia Schlagenhauf, Robert Steffen, Neuropsychiatric Events and Travel: Do Antimalarials Play a Role?, Journal of Travel Medicine, 2000, 7, 5
  47. 47
    R. Steffen, P. Schlagenhauf, La chimioprophylaxie du paludisme. Recommandations nationales et internationales: indications, efficacité, incidence des effets indésirables, Médecine et Maladies Infectieuses, 1999, 29, S385

    CrossRef

  48. 48
    Martin S. Wolfe, Travel medicine, Current Opinion in Infectious Diseases, 1999, 12, 5, 433

    CrossRef